Italy
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.71 (0.62 - 0.80) | 2019 | Modelled | IHME |
0.71 (0.62 - 0.80) | 2018 | Modelled | IHME |
0.72 (0.62 - 0.80) | 2017 | Modelled | IHME |
0.74 (0.64 - 0.82) | 2016 | Modelled | IHME |
0.76 (0.67 - 0.85) | 2015 | Modelled | IHME |
0.78 (0.69 - 0.87) | 2014 | Modelled | IHME |
0.8 (0.71 - 0.89) | 2013 | Modelled | IHME |
0.82 (0.72 - 0.91) | 2012 | Modelled | IHME |
0.83 (0.74 - 0.92) | 2011 | Modelled | IHME |
0.85 (0.75 - 0.95) | 2010 | Modelled | IHME |
0.87 (0.77 - 0.96) | 2009 | Modelled | IHME |
0.89 (0.80 - 0.99) | 2008 | Modelled | IHME |
0.91 (0.81 - 1.01) | 2007 | Modelled | IHME |
0.93 (0.83 - 1.03) | 2006 | Modelled | IHME |
0.95 (0.85 - 1.05) | 2005 | Modelled | IHME |
0.96 (0.86 - 1.06) | 2004 | Modelled | IHME |
0.98 (0.87 - 1.08) | 2003 | Modelled | IHME |
0.99 (0.89 - 1.09) | 2002 | Modelled | IHME |
1 (0.90 - 1.11) | 2001 | Modelled | IHME |
1.02 (0.92 - 1.13) | 2000 | Modelled | IHME |
1.04 (0.93 - 1.15) | 1999 | Modelled | IHME |
1.06 (0.96 - 1.17) | 1998 | Modelled | IHME |
1.09 (0.98 - 1.19) | 1997 | Modelled | IHME |
1.11 (1.01 - 1.22) | 1996 | Modelled | IHME |
1.14 (1.03 - 1.24) | 1995 | Modelled | IHME |
1.16 (1.05 - 1.27) | 1994 | Modelled | IHME |
1.18 (1.06 - 1.30) | 1993 | Modelled | IHME |
1.2 (1.08 - 1.32) | 1992 | Modelled | IHME |
1.22 (1.10 - 1.35) | 1991 | Modelled | IHME |
1.24 (1.11 - 1.38) | 1990 | Modelled | IHME |
0.7 (0.40 - 1) | 2016 | Modelled | ECDC |
0.5 (0.30 - 1) | 2007 | Survey/reported | Cozzolongo R et al, 2009 |
0.8 (0.40 - 1.30) | 2003 | Survey/reported | Pendino GM, 2005 |
0.7 (0 - 3.90) | 2001 | Survey/reported | Floreani A, 2006 |
1.7 (0.90 - 2.90) | 2014 | Survey/reported | Morisco, 2017 |
1.67 (1.26 - 2.17) | 2015 | Modelled | WHO |
0.6 (0.30 - 0.70) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
Showing out of
Show more
Children under-5 years
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.03 (0.02 - 0.03) | 2019 | Modelled | IHME |
0.03 (0.02 - 0.03) | 2018 | Modelled | IHME |
0.03 (0.02 - 0.03) | 2017 | Modelled | IHME |
0.03 (0.02 - 0.03) | 2016 | Modelled | IHME |
0.03 (0.02 - 0.03) | 2015 | Modelled | IHME |
0.03 (0.02 - 0.03) | 2014 | Modelled | IHME |
0.03 (0.02 - 0.03) | 2013 | Modelled | IHME |
0.03 (0.02 - 0.03) | 2012 | Modelled | IHME |
0.03 (0.02 - 0.03) | 2011 | Modelled | IHME |
0.03 (0.02 - 0.03) | 2010 | Modelled | IHME |
0.03 (0.02 - 0.03) | 2009 | Modelled | IHME |
0.03 (0.02 - 0.03) | 2008 | Modelled | IHME |
0.03 (0.02 - 0.04) | 2007 | Modelled | IHME |
0.03 (0.02 - 0.04) | 2006 | Modelled | IHME |
0.03 (0.02 - 0.04) | 2005 | Modelled | IHME |
0.03 (0.02 - 0.04) | 2004 | Modelled | IHME |
0.03 (0.02 - 0.04) | 2003 | Modelled | IHME |
0.03 (0.02 - 0.04) | 2002 | Modelled | IHME |
0.03 (0.02 - 0.04) | 2001 | Modelled | IHME |
0.03 (0.03 - 0.04) | 2000 | Modelled | IHME |
0.04 (0.03 - 0.05) | 1999 | Modelled | IHME |
0.04 (0.03 - 0.06) | 1998 | Modelled | IHME |
0.05 (0.04 - 0.06) | 1997 | Modelled | IHME |
0.06 (0.05 - 0.07) | 1996 | Modelled | IHME |
0.07 (0.05 - 0.09) | 1995 | Modelled | IHME |
0.08 (0.06 - 0.10) | 1994 | Modelled | IHME |
0.1 (0.08 - 0.13) | 1993 | Modelled | IHME |
0.13 (0.10 - 0.16) | 1992 | Modelled | IHME |
0.16 (0.12 - 0.20) | 1991 | Modelled | IHME |
0.19 (0.14 - 0.24) | 1990 | Modelled | IHME |
0.61 (0.39 - 0.93) | 2015 | Modelled | WHO |
Showing out of
Show more
Pregnant women
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.8 (0.70 - 1) | 2016 | Modelled | ECDC |
0.9 (0.70 - 1) | 2009 | Survey/reported | Spada E et al, 2014 |
0.8 (0.60 - 1) | 2012 | Survey/reported | Ruffini E et al, 2014 |
Showing out of
Show more
Prisoners
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
6.7 (5.20 - 8.40) | 2002 | Survey/reported | Babudieri S et al, 2005 |
Number of people living with chronic HBV
National
DownloadValue | Year | Type | Source |
---|---|---|---|
705,807 (631,542 - 781,770) | 1990 | Modelled | IHME |
694,015 (623,048 - 766,015) | 1991 | Modelled | IHME |
681,799 (614,734 - 750,737) | 1992 | Modelled | IHME |
669,159 (602,754 - 734,725) | 1993 | Modelled | IHME |
656,144 (591,929 - 719,604) | 1994 | Modelled | IHME |
642,982 (580,055 - 703,011) | 1995 | Modelled | IHME |
629,263 (567,391 - 688,677) | 1996 | Modelled | IHME |
615,000 (554,467 - 674,300) | 1997 | Modelled | IHME |
601,098 (539,853 - 660,145) | 1998 | Modelled | IHME |
588,603 (528,532 - 648,507) | 1999 | Modelled | IHME |
578,562 (518,853 - 637,545) | 2000 | Modelled | IHME |
571,242 (512,443 - 629,525) | 2001 | Modelled | IHME |
565,690 (507,325 - 624,039) | 2002 | Modelled | IHME |
561,302 (501,925 - 619,643) | 2003 | Modelled | IHME |
557,542 (498,855 - 615,206) | 2004 | Modelled | IHME |
552,972 (493,888 - 611,164) | 2005 | Modelled | IHME |
546,543 (488,580 - 604,822) | 2006 | Modelled | IHME |
538,782 (481,663 - 596,578) | 2007 | Modelled | IHME |
530,305 (474,113 - 587,670) | 2008 | Modelled | IHME |
521,436 (464,146 - 578,023) | 2009 | Modelled | IHME |
512,578 (454,087 - 570,369) | 2010 | Modelled | IHME |
504,104 (445,330 - 559,997) | 2011 | Modelled | IHME |
495,515 (437,630 - 550,410) | 2012 | Modelled | IHME |
486,353 (429,588 - 540,088) | 2013 | Modelled | IHME |
476,139 (419,444 - 529,176) | 2014 | Modelled | IHME |
464,269 (407,740 - 517,790) | 2015 | Modelled | IHME |
446,250 (390,392 - 498,698) | 2016 | Modelled | IHME |
433,593 (378,327 - 487,612) | 2017 | Modelled | IHME |
431,542 (377,511 - 486,066) | 2018 | Modelled | IHME |
430,090 (375,354 - 483,967) | 2019 | Modelled | IHME |
332,000 (202,000 - 430,000) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
Showing out of
Show more
HBV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
2.84 (2.52 - 3.19) | 2019 | Modelled | IHME |
2.77 (2.46 - 3.12) | 2018 | Modelled | IHME |
2.7 (2.39 - 3.03) | 2017 | Modelled | IHME |
2.61 (2.33 - 2.92) | 2016 | Modelled | IHME |
2.7 (2.41 - 3.02) | 2015 | Modelled | IHME |
2.67 (2.39 - 2.99) | 2014 | Modelled | IHME |
2.71 (2.42 - 3.03) | 2013 | Modelled | IHME |
2.75 (2.47 - 3.07) | 2012 | Modelled | IHME |
2.75 (2.48 - 3.07) | 2011 | Modelled | IHME |
2.77 (2.48 - 3.08) | 2010 | Modelled | IHME |
2.81 (2.53 - 3.13) | 2009 | Modelled | IHME |
2.88 (2.58 - 3.20) | 2008 | Modelled | IHME |
2.96 (2.66 - 3.29) | 2007 | Modelled | IHME |
3.07 (2.76 - 3.41) | 2006 | Modelled | IHME |
3.19 (2.87 - 3.55) | 2005 | Modelled | IHME |
3.34 (3 - 3.69) | 2004 | Modelled | IHME |
3.57 (3.21 - 3.93) | 2003 | Modelled | IHME |
3.74 (3.39 - 4.12) | 2002 | Modelled | IHME |
3.9 (3.53 - 4.30) | 2001 | Modelled | IHME |
4.04 (3.66 - 4.46) | 2000 | Modelled | IHME |
4.13 (3.73 - 4.55) | 1999 | Modelled | IHME |
4.14 (3.75 - 4.55) | 1998 | Modelled | IHME |
4.13 (3.74 - 4.55) | 1997 | Modelled | IHME |
4.13 (3.74 - 4.56) | 1996 | Modelled | IHME |
4.18 (3.78 - 4.60) | 1995 | Modelled | IHME |
4.3 (3.88 - 4.74) | 1994 | Modelled | IHME |
4.41 (3.99 - 4.87) | 1993 | Modelled | IHME |
4.57 (4.13 - 5.04) | 1992 | Modelled | IHME |
4.83 (4.37 - 5.31) | 1991 | Modelled | IHME |
5.03 (4.55 - 5.52) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
1,714 (1,517 - 1,927) | 2019 | Modelled | IHME |
1,676 (1,488 - 1,884) | 2018 | Modelled | IHME |
1,633 (1,451 - 1,836) | 2017 | Modelled | IHME |
1,587 (1,413 - 1,773) | 2016 | Modelled | IHME |
1,643 (1,465 - 1,834) | 2015 | Modelled | IHME |
1,626 (1,452 - 1,818) | 2014 | Modelled | IHME |
1,645 (1,474 - 1,841) | 2013 | Modelled | IHME |
1,670 (1,498 - 1,862) | 2012 | Modelled | IHME |
1,668 (1,500 - 1,860) | 2011 | Modelled | IHME |
1,669 (1,499 - 1,858) | 2010 | Modelled | IHME |
1,689 (1,518 - 1,881) | 2009 | Modelled | IHME |
1,716 (1,540 - 1,906) | 2008 | Modelled | IHME |
1,755 (1,574 - 1,946) | 2007 | Modelled | IHME |
1,805 (1,619 - 2,004) | 2006 | Modelled | IHME |
1,863 (1,673 - 2,069) | 2005 | Modelled | IHME |
1,933 (1,737 - 2,137) | 2004 | Modelled | IHME |
2,048 (1,845 - 2,257) | 2003 | Modelled | IHME |
2,138 (1,934 - 2,355) | 2002 | Modelled | IHME |
2,219 (2,008 - 2,446) | 2001 | Modelled | IHME |
2,290 (2,072 - 2,525) | 2000 | Modelled | IHME |
2,334 (2,111 - 2,572) | 1999 | Modelled | IHME |
2,336 (2,117 - 2,569) | 1998 | Modelled | IHME |
2,330 (2,109 - 2,568) | 1997 | Modelled | IHME |
2,333 (2,111 - 2,573) | 1996 | Modelled | IHME |
2,362 (2,136 - 2,600) | 1995 | Modelled | IHME |
2,432 (2,196 - 2,679) | 1994 | Modelled | IHME |
2,500 (2,261 - 2,758) | 1993 | Modelled | IHME |
2,595 (2,345 - 2,857) | 1992 | Modelled | IHME |
2,741 (2,481 - 3,012) | 1991 | Modelled | IHME |
2,854 (2,583 - 3,134) | 1990 | Modelled | IHME |
3,509 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
9 (8 - 11) | 2019 | Modelled | IHME |
9 (8 - 11) | 2018 | Modelled | IHME |
9 (8 - 11) | 2017 | Modelled | IHME |
9 (8 - 11) | 2016 | Modelled | IHME |
9 (8 - 10) | 2015 | Modelled | IHME |
9 (8 - 10) | 2014 | Modelled | IHME |
9 (8 - 10) | 2013 | Modelled | IHME |
9 (8 - 10) | 2012 | Modelled | IHME |
9 (8 - 10) | 2011 | Modelled | IHME |
9 (8 - 10) | 2010 | Modelled | IHME |
9 (8 - 11) | 2009 | Modelled | IHME |
9 (8 - 11) | 2008 | Modelled | IHME |
9 (8 - 11) | 2007 | Modelled | IHME |
9 (8 - 11) | 2006 | Modelled | IHME |
9 (8 - 11) | 2005 | Modelled | IHME |
10 (8 - 11) | 2004 | Modelled | IHME |
10 (8 - 12) | 2003 | Modelled | IHME |
10 (8 - 12) | 2002 | Modelled | IHME |
10 (8 - 12) | 2001 | Modelled | IHME |
10 (9 - 12) | 2000 | Modelled | IHME |
10 (9 - 13) | 1999 | Modelled | IHME |
11 (9 - 13) | 1998 | Modelled | IHME |
11 (9 - 13) | 1997 | Modelled | IHME |
11 (9 - 13) | 1996 | Modelled | IHME |
11 (9 - 13) | 1995 | Modelled | IHME |
11 (9 - 13) | 1994 | Modelled | IHME |
11 (9 - 13) | 1993 | Modelled | IHME |
11 (9 - 14) | 1992 | Modelled | IHME |
12 (10 - 14) | 1991 | Modelled | IHME |
12 (10 - 14) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
95 | 2018 | Survey/reported | WHO/UNICEF |
94 | 2017 | Survey/reported | WHO/UNICEF |
93 | 2016 | Survey/reported | WHO/UNICEF |
93 | 2015 | Survey/reported | WHO/UNICEF |
95 | 2014 | Survey/reported | WHO/UNICEF |
96 | 2013 | Survey/reported | WHO/UNICEF |
96 | 2012 | Survey/reported | WHO/UNICEF |
96 | 2011 | Survey/reported | WHO/UNICEF |
96 | 2010 | Survey/reported | WHO/UNICEF |
96 | 2009 | Survey/reported | WHO/UNICEF |
96 | 2008 | Survey/reported | WHO/UNICEF |
97 | 2007 | Survey/reported | WHO/UNICEF |
96 | 2006 | Survey/reported | WHO/UNICEF |
96 | 2005 | Survey/reported | WHO/UNICEF |
96 | 2004 | Survey/reported | WHO/UNICEF |
95 | 2003 | Survey/reported | WHO/UNICEF |
95 | 2002 | Survey/reported | WHO/UNICEF |
95 | 2001 | Survey/reported | WHO/UNICEF |
94 | 2000 | Survey/reported | WHO/UNICEF |
97 | 1999 | Survey/reported | WHO/UNICEF |
95 | 1998 | Survey/reported | WHO/UNICEF |
95 | 1997 | Survey/reported | WHO/UNICEF |
95 | 1996 | Survey/reported | WHO/UNICEF |
95 | 1995 | Survey/reported | WHO/UNICEF |
95 | 1994 | Survey/reported | WHO/UNICEF |
95 | 1993 | Survey/reported | WHO/UNICEF |
95 | 1992 | Survey/reported | WHO/UNICEF |
95 | 1991 | Survey/reported | WHO/UNICEF |
95 | 2019 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Percent of PWID accessing OST
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
30 | 2017 | Survey/reported | EMCDDA, 2019 |
HBV National Action Plan
HBV elimination goal
HBV testing policy
None
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
1.78 (1.44 - 2.19) | 2019 | Modelled | IHME |
1.77 (1.44 - 2.18) | 2018 | Modelled | IHME |
1.76 (1.42 - 2.16) | 2017 | Modelled | IHME |
1.72 (1.39 - 2.11) | 2016 | Modelled | IHME |
1.7 (1.37 - 2.07) | 2015 | Modelled | IHME |
1.72 (1.39 - 2.10) | 2014 | Modelled | IHME |
1.78 (1.44 - 2.18) | 2013 | Modelled | IHME |
1.86 (1.51 - 2.28) | 2012 | Modelled | IHME |
1.93 (1.56 - 2.35) | 2011 | Modelled | IHME |
1.96 (1.59 - 2.39) | 2010 | Modelled | IHME |
1.96 (1.60 - 2.39) | 2009 | Modelled | IHME |
1.96 (1.60 - 2.39) | 2008 | Modelled | IHME |
1.97 (1.60 - 2.39) | 2007 | Modelled | IHME |
1.97 (1.61 - 2.39) | 2006 | Modelled | IHME |
1.97 (1.61 - 2.39) | 2005 | Modelled | IHME |
2.02 (1.65 - 2.44) | 2004 | Modelled | IHME |
2.11 (1.73 - 2.55) | 2003 | Modelled | IHME |
2.22 (1.81 - 2.68) | 2002 | Modelled | IHME |
2.32 (1.89 - 2.80) | 2001 | Modelled | IHME |
2.35 (1.92 - 2.84) | 2000 | Modelled | IHME |
2.35 (1.92 - 2.84) | 1999 | Modelled | IHME |
2.35 (1.91 - 2.83) | 1998 | Modelled | IHME |
2.34 (1.91 - 2.83) | 1997 | Modelled | IHME |
2.33 (1.90 - 2.82) | 1996 | Modelled | IHME |
2.32 (1.89 - 2.81) | 1995 | Modelled | IHME |
2.29 (1.87 - 2.77) | 1994 | Modelled | IHME |
2.22 (1.82 - 2.69) | 1993 | Modelled | IHME |
2.13 (1.74 - 2.58) | 1992 | Modelled | IHME |
2.03 (1.65 - 2.46) | 1991 | Modelled | IHME |
1.91 (1.56 - 2.32) | 1990 | Modelled | IHME |
1.1 (0.70 - 1.30) | 2015 | Modelled | Blach et al, 2017 |
Showing out of
Show more
Pregnant women
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.39 (0.38 - 0.40) | 2018 | Survey/reported | Serological screening for hepatitis C during pregnancy: Seroprevalence and maternal and neonatal outcomes in 45,000 pregnant women |
Prevalence of anti-HCV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
5.9 (5.20 - 6.60) | 2016 | Modelled | ECDC |
3 (2.20 - 4.10) | 2014 | Survey/reported | Morisco, 2017 |
2.6 (2 - 3.40) | 2007 | Survey/reported | Cozzolongo R et al, 2009 |
6.5 (5.40 - 7.80) | 2003 | Survey/reported | Pendino GM, 2005 |
10.2 (8 - 12.70) | 2001 | Survey/reported | Floreani A, 2006 |
2 (1.60 - 7.30) | 2014 | Survey/reported | Gower et al, 2014 |
2.43 | 2019 | Modelled | Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis |
Showing out of
Show more
Men who have sex with men (MSM)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
2.6 | 2019 | Modelled | Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis |
Men who have sex with men
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
4.4 (2.10 - 7.20) | 2019 | Modelled | Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis |
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
57.9 (52.50 - 63.30) | 2014 | Modelled | Degenhardt L et al, 2017 |
60.5 (56.80 - 64) | 2010 | Survey/reported | EMCDDA |
Showing out of
Show more
Pregnant women
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
0.4 (0.30 - 0.50) | 2012 | Survey/reported | Ruffini E et al, 2014 |
Prisoners
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
38 (35 - 41.20) | 2002 | Survey/reported | Babudieri S et al, 2005 |
Number of people living with chronic HCV (RNA+/cAg)
National
DownloadValue | Year | Type | Source |
---|---|---|---|
1,083,300 (885,856 - 1,318,580) | 1990 | Modelled | IHME |
1,149,430 (937,590 - 1,394,610) | 1991 | Modelled | IHME |
1,209,540 (988,715 - 1,464,710) | 1992 | Modelled | IHME |
1,259,240 (1,029,220 - 1,525,500) | 1993 | Modelled | IHME |
1,294,230 (1,056,490 - 1,566,160) | 1994 | Modelled | IHME |
1,310,660 (1,068,460 - 1,587,470) | 1995 | Modelled | IHME |
1,316,360 (1,071,690 - 1,593,820) | 1996 | Modelled | IHME |
1,321,590 (1,076,060 - 1,597,430) | 1997 | Modelled | IHME |
1,326,220 (1,080,440 - 1,599,650) | 1998 | Modelled | IHME |
1,330,430 (1,084,370 - 1,602,980) | 1999 | Modelled | IHME |
1,334,420 (1,087,060 - 1,610,670) | 2000 | Modelled | IHME |
1,316,970 (1,073,430 - 1,590,050) | 2001 | Modelled | IHME |
1,269,760 (1,036,260 - 1,532,640) | 2002 | Modelled | IHME |
1,212,800 (991,171 - 1,466,200) | 2003 | Modelled | IHME |
1,166,590 (954,301 - 1,409,790) | 2004 | Modelled | IHME |
1,150,320 (940,178 - 1,394,270) | 2005 | Modelled | IHME |
1,156,230 (943,929 - 1,403,310) | 2006 | Modelled | IHME |
1,163,230 (948,739 - 1,415,370) | 2007 | Modelled | IHME |
1,170,560 (954,046 - 1,426,790) | 2008 | Modelled | IHME |
1,176,700 (957,514 - 1,433,240) | 2009 | Modelled | IHME |
1,180,210 (959,631 - 1,443,450) | 2010 | Modelled | IHME |
1,166,150 (946,371 - 1,425,590) | 2011 | Modelled | IHME |
1,129,490 (915,604 - 1,383,520) | 2012 | Modelled | IHME |
1,084,910 (876,063 - 1,327,560) | 2013 | Modelled | IHME |
1,047,180 (846,196 - 1,277,230) | 2014 | Modelled | IHME |
1,030,780 (832,762 - 1,256,210) | 2015 | Modelled | IHME |
1,046,310 (845,927 - 1,281,600) | 2016 | Modelled | IHME |
1,066,380 (862,514 - 1,305,960) | 2017 | Modelled | IHME |
1,073,190 (869,045 - 1,319,010) | 2018 | Modelled | IHME |
1,074,970 (869,359 - 1,320,490) | 2019 | Modelled | IHME |
680,000 (455,000 - 1,641,000) | 2015 | Modelled | Blach et al, 2017 |
Showing out of
Show more
HCV-related death rate
National
DownloadValue (per 100,000) | Year | Type | Source |
---|---|---|---|
13.3 (11.80 - 14.70) | 2019 | Modelled | IHME |
13.1 (11.60 - 14.30) | 2018 | Modelled | IHME |
12.7 (11.30 - 14) | 2017 | Modelled | IHME |
12.4 (11 - 13.60) | 2016 | Modelled | IHME |
12.9 (11.40 - 14.10) | 2015 | Modelled | IHME |
12.7 (11.30 - 13.90) | 2014 | Modelled | IHME |
12.9 (11.50 - 14.10) | 2013 | Modelled | IHME |
13 (11.60 - 14.20) | 2012 | Modelled | IHME |
13 (11.60 - 14.20) | 2011 | Modelled | IHME |
12.9 (11.50 - 14) | 2010 | Modelled | IHME |
12.8 (11.50 - 14) | 2009 | Modelled | IHME |
12.7 (11.40 - 13.90) | 2008 | Modelled | IHME |
12.6 (11.40 - 13.80) | 2007 | Modelled | IHME |
12.7 (11.40 - 13.90) | 2006 | Modelled | IHME |
12.8 (11.60 - 14) | 2005 | Modelled | IHME |
13.2 (11.90 - 14.40) | 2004 | Modelled | IHME |
13.8 (12.60 - 14.90) | 2003 | Modelled | IHME |
14.3 (13.10 - 15.50) | 2002 | Modelled | IHME |
14.6 (13.50 - 15.80) | 2001 | Modelled | IHME |
15 (13.80 - 16.20) | 2000 | Modelled | IHME |
15.3 (14.10 - 16.50) | 1999 | Modelled | IHME |
15.4 (14.20 - 16.70) | 1998 | Modelled | IHME |
15.5 (14.30 - 16.80) | 1997 | Modelled | IHME |
15.7 (14.50 - 17) | 1996 | Modelled | IHME |
15.8 (14.60 - 17.10) | 1995 | Modelled | IHME |
16.1 (14.80 - 17.30) | 1994 | Modelled | IHME |
16 (14.70 - 17.23) | 1993 | Modelled | IHME |
15.8 (14.50 - 17) | 1992 | Modelled | IHME |
15.7 (14.40 - 16.90) | 1991 | Modelled | IHME |
15.4 (14.20 - 16.60) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
DownloadValue | Year | Type | Source |
---|---|---|---|
8,050 (7,096 - 8,856) | 2019 | Modelled | IHME |
7,905 (7,007 - 8,662) | 2018 | Modelled | IHME |
7,719 (6,858 - 8,483) | 2017 | Modelled | IHME |
7,523 (6,682 - 8,238) | 2016 | Modelled | IHME |
7,811 (6,923 - 8,542) | 2015 | Modelled | IHME |
7,748 (6,896 - 8,468) | 2014 | Modelled | IHME |
7,816 (6,969 - 8,542) | 2013 | Modelled | IHME |
7,919 (7,057 - 8,637) | 2012 | Modelled | IHME |
7,861 (7,027 - 8,576) | 2011 | Modelled | IHME |
7,772 (6,962 - 8,476) | 2010 | Modelled | IHME |
7,709 (6,897 - 8,410) | 2009 | Modelled | IHME |
7,596 (6,822 - 8,292) | 2008 | Modelled | IHME |
7,477 (6,734 - 8,167) | 2007 | Modelled | IHME |
7,436 (6,715 - 8,140) | 2006 | Modelled | IHME |
7,486 (6,767 - 8,179) | 2005 | Modelled | IHME |
7,614 (6,909 - 8,313) | 2004 | Modelled | IHME |
7,904 (7,211 - 8,568) | 2003 | Modelled | IHME |
8,149 (7,465 - 8,829) | 2002 | Modelled | IHME |
8,318 (7,651 - 8,992) | 2001 | Modelled | IHME |
8,485 (7,839 - 9,180) | 2000 | Modelled | IHME |
8,644 (7,994 - 9,338) | 1999 | Modelled | IHME |
8,703 (8,043 - 9,427) | 1998 | Modelled | IHME |
8,768 (8,078 - 9,466) | 1997 | Modelled | IHME |
8,857 (8,161 - 9,577) | 1996 | Modelled | IHME |
8,950 (8,257 - 9,679) | 1995 | Modelled | IHME |
9,097 (8,384 - 9,798) | 1994 | Modelled | IHME |
9,036 (8,315 - 9,759) | 1993 | Modelled | IHME |
8,945 (8,204 - 9,662) | 1992 | Modelled | IHME |
8,894 (8,187 - 9,612) | 1991 | Modelled | IHME |
8,734 (8,050 - 9,446) | 1990 | Modelled | IHME |
10,470 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
58 (54 - 62) | 2019 | Modelled | IHME |
58 (54 - 62) | 2018 | Modelled | IHME |
58 (54 - 62) | 2017 | Modelled | IHME |
57 (53 - 61) | 2016 | Modelled | IHME |
57 (53 - 61) | 2015 | Modelled | IHME |
57 (53 - 61) | 2014 | Modelled | IHME |
57 (53 - 61) | 2013 | Modelled | IHME |
57 (53 - 61) | 2012 | Modelled | IHME |
57 (53 - 61) | 2011 | Modelled | IHME |
57 (53 - 61) | 2010 | Modelled | IHME |
57 (53 - 61) | 2009 | Modelled | IHME |
57 (53 - 61) | 2008 | Modelled | IHME |
57 (53 - 61) | 2007 | Modelled | IHME |
57 (53 - 60) | 2006 | Modelled | IHME |
56 (52 - 60) | 2005 | Modelled | IHME |
56 (52 - 60) | 2004 | Modelled | IHME |
56 (52 - 60) | 2003 | Modelled | IHME |
55 (51 - 60) | 2002 | Modelled | IHME |
55 (51 - 59) | 2001 | Modelled | IHME |
55 (51 - 59) | 2000 | Modelled | IHME |
54 (50 - 59) | 1999 | Modelled | IHME |
54 (50 - 59) | 1998 | Modelled | IHME |
55 (50 - 59) | 1997 | Modelled | IHME |
55 (50 - 59) | 1996 | Modelled | IHME |
54 (50 - 59) | 1995 | Modelled | IHME |
54 (50 - 59) | 1994 | Modelled | IHME |
54 (50 - 58) | 1993 | Modelled | IHME |
54 (50 - 58) | 1992 | Modelled | IHME |
54 (50 - 58) | 1991 | Modelled | IHME |
54 (49 - 58) | 1990 | Modelled | IHME |
Showing out of
Show more
Percent of PWID accessing OST
People who inject drugs (PWID)
DownloadValue (%) | Year | Type | Source |
---|---|---|---|
30 | 2017 | Survey/reported | EMCDDA, 2019 |
HBV National Action Plan
HBV elimination goal
HBV testing policy
None
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
Hepatitis related deaths (national)
Prevalence < 5
HBV
0.03
(%)
2019, latest modelled
(0.02 - 0.03(%))
IHME
Prevalence PWID
HCV
60.50
(%)
2010, survey/surveillance
(56.80 - 64(%))
EMCDDA
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
No. of syringes/PWID/year
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines